Guggenheim Starts Kythera Biopharmaceuticals (KYTH) at Buy
Tweet
Share
E-mailGet Alerts KYTH Hot Sheet
Price: $74.98 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Guggenheim initiated coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Buy rating and a price target of $64.00.
For an analyst ratings summary and ratings history on Kythera Biopharmaceuticals click here. For more ratings news on Kythera Biopharmaceuticals click here.
Shares of Kythera Biopharmaceuticals closed at $52.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
- ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
